Sickle cell disease: a review
PL Kavanagh, TA Fasipe, T Wun - Jama, 2022 - jamanetwork.com
Importance Sickle cell disease (SCD) is an inherited disorder of hemoglobin, characterized
by formation of long chains of hemoglobin when deoxygenated within capillary beds …
by formation of long chains of hemoglobin when deoxygenated within capillary beds …
Pathophysiology of sickle cell disease
Since the discovery of sickle cell disease (SCD) in 1910, enormous strides have been made
in the elucidation of the pathogenesis of its protean complications, which has inspired recent …
in the elucidation of the pathogenesis of its protean complications, which has inspired recent …
Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …
L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …
A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
Special Issue Writing Committee is charged with reviewing, updating and categorizing …
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
Y Niihara, ST Miller, J Kanter, S Lanzkron… - … England Journal of …, 2018 - Mass Medical Soc
Background Oxidative stress contributes to the complex pathophysiology of sickle cell
disease. Oral therapy with pharmaceutical-grade l-glutamine (USAN, glutamine) has been …
disease. Oral therapy with pharmaceutical-grade l-glutamine (USAN, glutamine) has been …
Sickle cell disease
Sickle cell disease (SCD) is a group of inherited disorders caused by mutations in HBB,
which encodes haemoglobin subunit β. The incidence is estimated to be between 300,000 …
which encodes haemoglobin subunit β. The incidence is estimated to be between 300,000 …
Understanding sickle cell disease: causes, symptoms, and treatment options
C Elendu, DC Amaechi, CE Alakwe-Ojimba… - Medicine, 2023 - journals.lww.com
Sickle cell disease (SCD) is a hereditary blood disorder characterized by the production of
abnormal hemoglobin molecules that cause red blood cells to take on a crescent or sickle …
abnormal hemoglobin molecules that cause red blood cells to take on a crescent or sickle …
Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …
J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support
In July 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …
Review included limited searches for new evidence and discussion of the search results …
Sickle cell disease
Sickle cell disease is caused by an alteration in a single DNA base, but its clinical
manifestations are influenced by other genes and behavioral and environmental factors …
manifestations are influenced by other genes and behavioral and environmental factors …